Breast Cancer
From the Journals
CVD risk after breast cancer: Adipose distribution trumps BMI
The more fat that breast cancer survivors had in the visceral compartment or intramuscular compartment, the higher their CVD risk, regardless of...
From the Journals
Cost a factor in breast cancer treatment decisions
Though cost was a significant factor in decisions about surgical options, more than three-quarters of women said they never discussed costs with...
From the Journals
ctDNA may predict relapse risk in early breast cancer
Circulating tumor DNA was associated with a significant risk for relapse in women treated for early primary breast cancers.
From the Journals
Results support first-line T-DM1 in HER2+ breast cancer
A phase 3 trial showed similar overall survival times in patients who received trastuzumab emtansine (T-DM1), T-DM1 plus pertuzumab, or...
From the Journals
Depression, anxiety among elderly breast cancer survivors linked to increased opioid use, death
Among 10,452 breast cancer survivors prescribed adjuvant endocrine therapy, those with mental health comorbidities were 33% more likely to use...
From the Journals
Standard chemotherapy remains superior in early breast cancer
The 10-year recurrence-free survival rates were 56% with standard chemotherapy versus 50% with capecitabine in a randomized noninferiority trial...
From the Journals
Comorbidities drive excess mortality after breast cancer diagnosis in childhood cancer survivors
A retrospective analysis found that, among matched breast cancer patients, childhood cancer survivors had a more than doubling of all-cause...
From the Journals
Racial, age disparities confirmed in triple-negative breast cancer
In a cohort of more than a million breast cancer cases, likelihood of having a tumor with the TNBC phenotype was roughly twice as high for black...
From the Journals
Increased cancer death linked to radioactive iodine therapy
From the Journals
Breast density alone should not prompt supplemental imaging discussions
From the Journals
CVD risk upped in postmenopausal breast cancer survivors
Overall, breast cancer patients had significantly higher HSP60 levels and lower HSP70 levels than those of their cancer-free peers.